G. Maconi et al., Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?, DIG LIVER D, 32(4), 2000, pp. 275-280
Aims. To compare the efficacy of one-week versus two-week treatment with la
nsoprazole, amoxycillin and clarithromycin in inducing healing of Helicobac
ter pylori-positive duodenal ulcers as well as to investigate the role of s
everal factors, determinant in the ulcer healing process.
Patients and methods. Seventy-one active duodenal ulcer patients were rando
mised to receive one- or two-week treatment with lansoprazole (30 mg bid),
clarithromycin (500 mg bid) and amoxycillin (1 g bid), not followed by any
additional acid suppressive therapy. Ulcer healing and Helicobacter pylori
infection were assessed by endoscopy and urea breath test 4 weeks after the
end of treatment. Before entering the trial and four weeks after the end o
f treatment, dyspeptic symptoms were recorded and scored by a validated que
stionnaire. The potential effects of a number of clinical variables on the
ulcer healing process were evaluated by means of univariate and multivariat
e analyses.
Results. Duodenal ulcer was healed in 80.5% patients treated for one week a
nd in 91.4% patients treated for 2 weeks according to intention-to-treat an
alysis (p=NS). Ulcer healing was more frequent in the Helicobacter pylori c
ured patients compared to those with persisting infection (90.9% vs 68.5%;
p=0.04). Multivariate analysis did not reveal any significant predictor of
duodenal ulcer healing.
Conclusions. Two-week treatment with lansoprazole, amoxycillin and clarithr
omycin, without continuation of antisecretive therapy, is better: although
the difference is not statistically significant, than one-week treatment in
healing Helicobacter pylori-positive duodenal ulcer disease. The eradicati
on of Helicobacter pylori is the most important factor related to ulcer hea
ling.